Characterization of clinically-attenuated Burkholderia mallei by whole genome sequencing: Candidate strain for exclusion from Select Agent lists

PLoS ONE

Volumn 3, Issue 4, 2008, Pages

  Schutzer, Steven E ^a   Schlater, Linda R K ^b   Ronning, Catherine M ^c   DeSchazer, David ^d   Luft, Benjamin J ^e   Dunn, John J ^f   Ravel, Jacques ^g   Fraser Liggett, Claire M ^g   Nierman, William C ^c,h  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

^c J CRAIG VENTER INSTITUTE   (United States)

^d UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^e STONY BROOK UNIVERSITY   (United States)

^f BROOKHAVEN NATIONAL LABORATORY   (United States)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; TYPE III SECRETION APPARATUS PROTEIN HRPE; TYPE III SECRETION APPARATUS PROTEIN YSCL; TYPE III SECRETION CHAPERONE BICA; TYPE III SECRETION CHAPERONE BICP; TYPE III SECRETION INNER MEMBRANE PROTEIN; TYPE III SECRETION INNER MEMBRANE PROTEIN SCTL; TYPE III SECRETION INNER MEMBRANE PROTEIN SCTQ; TYPE III SECRETION INNER MEMBRANE PROTEIN SCTR; TYPE III SECRETION INNER MEMBRANE PROTEIN SCTS; TYPE III SECRETION INNER MEMBRANE PROTEIN SCTV; TYPE III SECRETION PROTEIN HRPB2; TYPE III SECRETION PROTEIN HRPB4; TYPE III SECRETION PROTEIN YSCU; TYPE III SECRETION SYSTEM BASJ; TYPE III SECRETION SYSTEM PROTEIN; TYPE III SECRETION SYSTEM PROTEIN BSAL; TYPE III SECRETION SYSTEM PROTEIN BSAM; TYPE III SECRETION SYSTEM PROTEIN BSAO; TYPE III SECRETION SYSTEM PROTEIN BSAP; TYPE III SECRETION SYSTEM PROTEIN BSAQ; TYPE III SECRETION SYSTEM PROTEIN BSAR; TYPE III SECRETION SYSTEM PROTEIN BSAS; TYPE III SECRETION SYSTEM PROTEIN BSAV; TYPE III SECRETION SYSTEM PROTEIN BSAW; TYPE III SECRETION SYSTEM PROTEIN BSAX; TYPE III SECRETION SYSTEM PROTEIN BSAY; TYPE III SECRETION SYSTEM PROTEIN BSAZ; TYPE III SECRETION SYSTEM TRANSCRIPTIONAL REGULATOR BSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL GENOME; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BURKHOLDERIA MALLEI; DONKEY; GENE DELETION; GENE FUNCTION; GENE INSERTION SEQUENCE; GENE LOSS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; HAMSTER; HORSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPIC VARIATION; STRAIN DIFFERENCE; ANIMAL; BACTERIAL CHROMOSOME; BACTERIAL GENE; COMPUTER PROGRAM; DNA SEQUENCE; GENETICS; METHODOLOGY; MICROBIOLOGY; PATHOGENICITY; PHENOTYPE; VIRULENCE;

ANIMALIA; BURKHOLDERIA MALLEI; CRICETINAE; EQUIDAE; EQUUS ASINUS; MUS;

ANIMALS; BACTERIAL PROTEINS; BURKHOLDERIA MALLEI; CHROMOSOMES, BACTERIAL; EQUIDAE; GENES, BACTERIAL; GENOME, BACTERIAL; PHENOTYPE; SEQUENCE ANALYSIS, DNA; SOFTWARE; VIRULENCE;

EID: 44349175992     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002058     Document Type: Article

References (30)

1. Wilkinson L (1981) Glanders: medicine and veterinary medicine in common pursuit of a contagious disease. Medical History 25: 363-384.
2. Whitlock GC, Estes DM, Torres AG (2007) Glanders: off to the races with Burkholderia mallei. FEMS Microbiol Lett 277: 115-122.
3. CDC (2000) Glanders (Burkholderia mallei) http://www.cdc.gov/neidod/dbmd/ diseaseinfo/glanders_g.htm.
4. CDC et al (2000) Laboratoy-acquired human glanders-Maryland, May 2000. MMWR Morb Mortal Wkly Rep 49: 532-535.
5. Fraser CM (1991) The Merck veterinary manual-a handbook of diagnosis, therapy, and disease prevention and control for the veterinarian. Rahway, NJ: Merck & Co.
6. Mandell GL, Douglas RG, Bennett JE (1995) Mandell, Douglas and Bennett's principles and practice of infectious diseases. New York: Churchill Livingstone.
7. Geissler E, Moon JEvC, Stockholm International Peace Research Institute (1999) Biological and toxin weapons research, development and use from the Middle Ages to 1945. Oxford: Oxford University Press.
8. Wheelis M (1998) First shots fired in biological warfare. Nature 395: 213.
9. Congressional Research Service (CRS), Shea DA, Gorttron F (2004) Small-scale Terrorist Attacks Using Chemical and Biological Agents (updated)(also at www.fas.org/irp/crs/RL32391-062304.pdf. RL32391.
10. Department of Health and Human Services ASfPaR (2007) http://www.hhs.gov/ aspr/barda/documents/phemce_implplan_041607final.pdf.
11. Koenig RL (2006) The Fourth Horseman: One Man's Secret Campaign to Fight the Great War in America. New York: Public Affairs.
12. Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, et al. (1997) Clinical recognition and management of patients exposed to biological warfare agents. JAMA 278: 399-411.
13. Kortpeter M, Christopher GW, Cieslak T, Culpepper R, Darling R, et al. (2001) USAMRIID's Medical management of biological casualties handbook. Fort Detrick: U.S. Army Medical Research Institute of Infectious Diseases.
14. Fritz DL, Vogel P, Brown DR, DeShazer D, Waag DM (2000) Mouse model of sublethal and lethal intraperitoneal glanders (Burkholderia mallei). Vet Pathol 37: 626-636.
15. Ulrich RL, DeShazer D (2004) Type III secretion: a virulence factor delivery system essential for the pathogenicity of Burkholderia mallei. Infect Immun 72: 1150-1154.
16. DeShazer D, Waag DM, Fritz DL, Woods DE (2001) Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant. Microb Pathog 30: 253-269.
17. Schell MA, Ulrich RL, Ribot WJ, Brueggemann EE, Hines HB, et al. (2007) Type VI secretion is a major virulence determinant in Burkholderia mallei. Mol Microbiol 64: 1466-1485.
18. Yabuuchi E, Kosako Y, Oyaizu H, Yano I, Hotta H, et al. (1992) Proposal of Burkholderia. gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiology & Immunology 36: 1251-1275.
19. Srinivasan A, Kraus CN, DeShazer D, Becker PM, Dick JD, et al. (2001) Glanders in a military research microbiologist. N Engl J Med 345: 256-258.
20. Fritz DL, Vogel P, Brown DR, Waag DM (1999) The hamster model of intraperitoneal Burkholderia mallei (glanders). Veterinary Pathology 36: 276-291.
21. Lopez J, Copps J, Wilhelmsen C, Moore R, Kubay J, et al. (2003) Characterization of experimental equine glanders. Microbes Infect 5: 1125-1131.
22. Nierman WC, DeShazer D, Kim HS, Tettelin H, Nelson KE, et al. (2004) Structural flexibility in the Burkholderia mallei genome. Proc Natl Acad Sci U S A 101: 14246-14251.
23. Centers for Disease Control and Prevention (2005) Select Agent Program. http://www.cdc.gov/od/sap/.
24. US Department of Agriculture A (2005) Agricultural Bioterrorism Protection Act of 2002; Possession, Use, and Transfer of Biological Agents and Toxins. Federal Register 70: 13242-13292.
25. Centers for Disease Control and Prevention (2006) Select Agent Program Notification of Exclusion. http://www.cdc.gov/od/sap/sap/exclusion.htm.
26. Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, et al. (1995) Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269: 496-512.
27. Waterman MS (1988) Computer analysis of nucleic acid sequences. Methods Enzymol 164: 765-793.
28. Haas BJ, Delcher AL, Mount SM, Wortman JR, Smith RK Jr, et al. (2003) Improving the Arabidopsis genome annotation using maximal transcript alignment assemblies. Nucleic Acids Res 31: 5654-5666.
29. Kent WJ, Sugnet CW, Furey TS, Ruskin KM, Pringle TH, et al. (2002) The human genome browser at UCSC. Genome Res 12: 996-1006.
30. Florea L, Hartzell G, Zhang Z, Rubin GM, Miller W (1998) A computer program for aligning a cDNA sequence with a genomic, DNA sequence. Genome Res 8: 967-974.